Imran Khan/Proem reports staged DAVE stock disposals via 10b5-1 plan
Rhea-AI Filing Summary
Insider sales by an affiliate of Proem funds were disclosed on Form 4 for Dave Inc. (DAVE). Imran Khan, reporting as a director and on behalf of Proem Investments Master Fund, LP and Proem Special Situations Fund I, LP, reported multiple sales of Class A common stock on 09/15/2025 and 09/16/2025 executed under a Rule 10b5-1 trading plan adopted March 14, 2025. The filing lists numerous dispositions at weighted-average prices across specified ranges, and shows the reporting person’s beneficial ownership declining stepwise in the reported lines to amounts such as 67,761 shares following the last reported sale. The filer notes this is the first of three Form 4s to be filed for these transactions.
Positive
- Sales executed under a Rule 10b5-1 trading plan adopted March 14, 2025, indicating pre-scheduled dispositions
- Detailed disclosure of weighted-average price ranges and an undertaking to provide per-price sale counts upon request
- Reporting includes stepwise beneficial ownership amounts after each reported sale, improving transparency
Negative
- Multiple sizable dispositions by Proem-affiliated funds across 09/15/2025 and 09/16/2025 reducing reported beneficial ownership
- Three Form 4s required due to transaction volume, indicating material total sales that may affect free float or market perception
Insights
TL;DR: Multiple planned disposals by an affiliated fund, disclosed transparently under a 10b5-1 plan; impact appears routine.
The transactions are reported as sales under a pre-existing Rule 10b5-1 plan, which typically indicates scheduled, non-discretionary dispositions rather than opportunistic insider selling. The Form 4 lists many separate disposals across two dates with weighted-average prices and resulting beneficial ownership counts after each trade. From an investor-analysis perspective, these filings increase trading transparency and supply precise price ranges for the reported sales, but the filing itself does not disclose any company operational changes or insider intent beyond the plan parameters.
TL;DR: Governance disclosure standards met; sales executed under an explicit 10b5-1 plan and fully explained in remarks.
The report identifies the reporting person, relationship to the issuer, and documents that the sales were executed pursuant to a Rule 10b5-1 plan adopted March 14, 2025. The explanatory remarks provide weighted-average price ranges and commit to furnish detailed per-price sale counts on request. The filer also states this is the first of three contemporaneous Form 4s, which is appropriate when reporting-system limits are reached. These details reflect compliance with Section 16 reporting obligations and enhanced traceability of fund-affiliated insider sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 1,022 | $207.47 | $212K |
| Sale | Class A Common Stock | 678 | $208.07 | $141K |
| Sale | Class A Common Stock | 2,818 | $209.78 | $591K |
| Sale | Class A Common Stock | 3,382 | $210.81 | $713K |
| Sale | Class A Common Stock | 1,534 | $211.75 | $325K |
| Sale | Class A Common Stock | 1,932 | $212.72 | $411K |
| Sale | Class A Common Stock | 3,200 | $218.77 | $700K |
| Sale | Class A Common Stock | 1,867 | $219.91 | $411K |
| Sale | Class A Common Stock | 2,078 | $220.79 | $459K |
| Sale | Class A Common Stock | 1,455 | $221.93 | $323K |
| Sale | Class A Common Stock | 2,396 | $222.94 | $534K |
| Sale | Class A Common Stock | 1,469 | $224.02 | $329K |
| Sale | Class A Common Stock | 2,615 | $224.98 | $588K |
| Sale | Class A Common Stock | 1,195 | $225.78 | $270K |
| Sale | Class A Common Stock | 1,125 | $226.88 | $255K |
| Sale | Class A Common Stock | 500 | $227.97 | $114K |
| Sale | Class A Common Stock | 1,500 | $229.23 | $344K |
| Sale | Class A Common Stock | 359 | $229.96 | $83K |
| Sale | Class A Common Stock | 3,111 | $218.66 | $680K |
| Sale | Class A Common Stock | 2,355 | $219.95 | $518K |
| Sale | Class A Common Stock | 1,647 | $220.80 | $364K |
| Sale | Class A Common Stock | 1,617 | $221.85 | $359K |
| Sale | Class A Common Stock | 2,175 | $222.84 | $485K |
| Sale | Class A Common Stock | 1,168 | $223.90 | $262K |
| Sale | Class A Common Stock | 2,980 | $224.85 | $670K |
| Sale | Class A Common Stock | 1,362 | $225.77 | $307K |
| Sale | Class A Common Stock | 1,092 | $226.92 | $248K |
| Sale | Class A Common Stock | 404 | $228.02 | $92K |
| Sale | Class A Common Stock | 1,295 | $229.16 | $297K |
| Sale | Class A Common Stock | 569 | $229.86 | $131K |
Footnotes (1)
- The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on behalf of Proem Investments Master Fund, LP and Proem Special Situations Fund I, LP on March 14, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.26 to $219.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.40 to $220.39, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.41 to $221.35, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.41 to $222.32, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.50 to $223.49, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.50 to $224.48, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.50 to $225.47, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.50 to $226.45, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.50 to $227.33, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.64 to $228.54, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.85 to $229.77, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.86 to $230.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.26 to $219.19, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.41 to $221.39, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.42 to $222.40, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.42 to $223.38, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.45 to $224.44, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.45 to $225.42, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.46 to $226.46, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.46 to $227.40, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.50 to $228.49, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.62 to $229.58, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.62 to $230.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.84 to $207.80, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.88 to $208.20, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.28 to $210.23, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.30 to $211.25, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.30 to $212.29, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.30 to $213.26, inclusive.